InvestorsObserver
×
News Home

Should Medical Devices Stock Soliton Inc (SOLY) Be in Your Portfolio Tuesday?

Tuesday, December 14, 2021 02:05 PM | InvestorsObserver Analysts

Mentioned in this article

Should Medical Devices Stock Soliton Inc (SOLY) Be in Your Portfolio Tuesday?

The 58 rating InvestorsObserver gives to Soliton Inc (SOLY) stock puts it near the top of the Medical Devices industry. In addition to scoring higher than 89 percent of stocks in the Medical Devices industry, SOLY’s 58 overall rating means the stock scores better than 58 percent of all stocks.

Overall Score - 58
SOLY has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on SOLY!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes

InvestorsObserver

’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Soliton Inc Stock Today?

Soliton Inc (SOLY) stock is up 11.94% while the S&P 500 is lower by -1.27% as of 2:00 PM on Tuesday, Dec 14. SOLY has risen $2.41 from the previous closing price of $20.14 on volume of 3,006,154 shares. Over the past year the S&P 500 has risen 26.38% while SOLY has risen 160.09%. SOLY lost -$0.84 per share the over the last 12 months. Click Here to get the full Stock Report for Soliton Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App